Home Catalogue search

eng

Refine your search:

Search in the Catalogues and Directories






	Sort by
Simple Search

Hits 1 – 6 of 6

1	Cross-cultural neuropsychological assessment in Europe: Position statement of the European Consortium on Cross-Cultural Neuropsychology (ECCroN)
	Franzen, Sanne; European Consortium On Cross-Cultural Neuropsychology ECCroN,; Bekkhus-Wetterberg, Peter. - : Taylor & Francis, 2022
	BASE
	Show details

2	Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
	Panman, Jessica L; Venkatraghavan, Vikram; van der Ende, Emma L...
	In: J Neurol Neurosurg Psychiatry (2021)
	BASE
	Show details

3	Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
	Bergeron, David; Gorno-Tempini, Maria; Rabinovici, Gil...
	In: ISSN: 0364-5134 ; EISSN: 1531-8249 ; Annals of Neurology ; https://hal-univ-fcomte.archives-ouvertes.fr/hal-03630161 ; Annals of Neurology, Wiley, 2018, 84 (5), pp.729-740. ⟨10.1002/ana.25333⟩ (2018)
	BASE
	Show details

4	Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
	Bergeron, David; Gorno-Tempini, Maria,; Rabinovici, Gil,; Santos-Santos, Miguel,; Seeley, William; Miller, Bruce,; Pijnenburg, Yolande; Keulen, M Antoinette; Groot, Colin; Van Berckel, Bart,; Van Der Flier, Wiesje,; Scheltens, Philip; Rohrer, Jonathan,; Warren, Jason,; Schott, Jonathan,; Fox, Nick,; Sánchez-Valle, Raquel; Grau-Rivera, Oriol; Gelpi, Ellen; Seelaar, Harro; Papma, Janne,; Van Swieten, John,; Hodges, John,; Leyton, Cristian,; Piguet, Olivier; Rogalski, Emily,; Mesulam, Marsel,; Koric, Lejla; Nora, Kristensen; Pariente, Jeéreémie; Dickerson, Bradford; Mackenzie, Ian,; Hsiung, Ging-Yuek,; Belliard, Serge; Irwin, David,; Wolk, David,; Grossman, Murray; Jones, Matthew; Harris, Jennifer; Mann, David; Snowden, Julie,; Chrem-Mendez, Patricio; Calandri, Ismael,; Amengual, Alejandra,; Miguet-Alfonsi, Carole; Magnin, Eloi; Magnani, Giuseppe; Santangelo, Roberto; Deramecourt, Vincent; Pasquier, Florence; Mattsson, Niklas; Nilsson, Christer; Hansson, Oskar; Keith, Julia; Masellis, Mario; Black, Sandra,; Matías-Guiu, Jordi,; Cabrera-Martin, María-Nieves; Paquet, Claire; Dumurgier, Julien; Teichmann, Marc; Sarazin, Marie; Bottlaender, Michel; Dubois, Bruno; Rowe, Christopher,; Villemagne, Victor,; Vandenberghe, Rik; Granadillo, Elias; Teng, Edmond; Mendez, Mario; Meyer, Philipp,; Frings, Lars; Lleó, Alberto; Blesa, Rafael; Fortea, Juan; Seo, Sang Won; Diehl-Schmid, Janine; Grimmer, Timo; Frederiksen, Kristian Steen; Sánchez-Juan, Pascual; Chételat, Gaël; Jansen, Willemijn; Bouchard, Rémi,; Laforce, Robert Jr; Visser, Pieter Jelle; Ossenkoppele, Rik
	In: ISSN: 0364-5134 ; EISSN: 1531-8249 ; Annals of Neurology ; https://www.hal.inserm.fr/inserm-02749861 ; Annals of Neurology, Wiley, 2018, 84 (5), pp.729-740. ⟨10.1002/ana.25333⟩ (2018)
	Abstract: International audience ; Objective: To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants.Methods: We conducted a meta-analysis with individual participant data from 1,251 patients diagnosed with PPA (including logopenic [lvPPA, n = 443], nonfluent [nfvPPA, n = 333], semantic [svPPA, n = 401], and mixed/unclassifiable [n = 74] variants of PPA) from 36 centers, with a measure of amyloid-β pathology (CSF [n = 600], PET [n = 366], and/or autopsy [n = 378]) available. The estimated prevalence of amyloid positivity according to PPA variant, age, and apolipoprotein E (ApoE) ε4 status was determined using generalized estimating equation models.Results: Amyloid-β positivity was more prevalent in lvPPA (86%) than in nfvPPA (20%) or svPPA (16%; p < 0.001). Prevalence of amyloid-β positivity increased with age in nfvPPA (from 10% at age 50 years to 27% at age 80 years, p < 0.01) and svPPA (from 6% at age 50 years to 32% at age 80 years, p < 0.001), but not in lvPPA (p = 0.94). Across PPA variants, ApoE ε4 carriers were more often amyloid-β positive (58.0%) than noncarriers (35.0%, p < 0.001). Autopsy data revealed Alzheimer disease pathology as the most common pathologic diagnosis in lvPPA (76%), frontotemporal lobar degeneration-TDP-43 in svPPA (80%), and frontotemporal lobar degeneration-TDP-43/tau in nfvPPA (64%).Interpretation: This study shows that the current PPA classification system helps to predict underlying pathology across different cohorts and clinical settings, and suggests that age and ApoE genotype should be considered when interpreting amyloid-β biomarkers in PPA patients. Ann Neurol 2018;84:737-748.
	Keyword: [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
	URL: https://doi.org/10.1002/ana.25333 https://www.hal.inserm.fr/inserm-02749861
	BASE
	Hide details

5	Prevalence of Amyloid-β Pathology in Distinct Variants of Primary Progressive Aphasia
	Bergeron, David; Gorno-Tempini, Maria L.; Rabinovici, Gil D.. - 2018
	BASE
	Show details

6	Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia: Amyloid-β Pathology in PPA
	Bergeron, David; Gorno-Tempini, Maria L.; Rabinovici, Gil D....
	In: Annals of Neurology. - 84, 5 (2018) , 729-740, ISSN: 0364-5134 (2018)
	BASE
	Show details

© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern